Search Results

You are looking at 1 - 10 of 570 items for :

  • "supportive care" x
Clear All
Full access

Noopur S. Raje, Andrew J. Yee and G. David Roodman

not curable, increasingly more patients are living with MM for longer periods as survival improves. The focus has centered on maximizing quality of life for patients with MM. Improvements in supportive care will allow patients to gain the benefit of

Full access

Young D. Chang, Jae-Woo Jung, Ritika Oberoi-Jassal, Jongphil Kim, Sahana Rajasekhara, Meghan Haas, Joshua Smith, Vijay Desai, Kristine A. Donovan and Diane Portman

supportive care setting, it is not surprising that patient and family inquiries about purported cannabinoid benefits for common cancer-related symptoms, such as pain, nausea, and poor appetite, have become more frequent as medical marijuana programs have

Full access

Sharon Spencer

the practical aspects of dose delivery to a patient, successful outcome of patient treatments, and convenience to the staff delivering the treatment. Supportive Care All professionals caring for patients with H&N cancer should assess supportive

Full access

Amy A. Kirkham, Kelcey A. Bland, Holly Wollmann, Alis Bonsignore, Don C. McKenzie, Cheri Van Patten, Karen A. Gelmon and Kristin Campbell

dietitians is limited. Although exercise training can be beneficial during and after treatment, intervention during chemotherapy may be especially important as supportive care in managing treatment-related side effects. With respect to exercise during

Full access

Willemieke P.M. Dijksterhuis, Anouk E.J. Latenstein, Jessy Joy van Kleef, Rob H.A. Verhoeven, Jeanne H.M. de Vries, Marije Slingerland, Elles Steenhagen, Joos Heisterkamp, Liesbeth M. Timmermans, Marian A.E. de van der Schueren, Martijn G.H. van Oijen, Sandra Beijer and Hanneke W.M. van Laarhoven

resection (± adjuvant chemotherapy), (3) a resection without neoadjuvant treatment, (4) definitive chemoradiotherapy (dCRT; ie, chemotherapy and concurrent long-term radiotherapy without a resection), (5) palliative chemotherapy, and (6) best supportive care

Full access

supportive care were also examined. Results: nab-P was associated with significantly longer TTD than eribulin in HR+/HER2− MBC ( Table 1 ). Granulocyte colony-stimulating factor (G-CSF) and antiemetics were used less with nab-P in both HR+/HER2− and TN MBC

Full access

Michael H. Levy, Anthony Back, Costantino Benedetti, J. Andrew Billings, Susan Block, Barry Boston, Eduardo Bruera, Sydney Dy, Catherine Eberle, Kathleen M. Foley, Sloan Beth Karver, Sara J. Knight, Sumathi Misra, Christine S. Ritchie, David Spiegel, Linda Sutton, Susan Urba, Jamie H. Von Roenn and Sharon M. Weinstein

– 168 . 29 Levy MH . Supportive oncologypalliative care: what’s in a name? Semin Oncol 2005 ; 32 : 131 – 133 . 30 Khatcheressian J Cassel JB Lyckholm L . Improving palliative and supportive care in cancer patients . Oncology

Full access

Paolo Marchetti, Raymond Voltz, Carmen Rubio, Didier Mayeur and Andreas Kopf

minutes), and variable frequency. Outcomes In a cohort of 208 patients with cancer admitted for oncology inpatient supportive care from May 2002 to May 2004, 38% had 1 to 2 severe symptoms at hospital admission, 31% had 3 to 4 severe symptoms, 22

Full access

Héctor G. van den Boorn, Ameen Abu-Hanna, Nadia Haj Mohammad, Maarten C.C.M. Hulshof, Suzanne S. Gisbertz, Bastiaan R. Klarenbeek, Marije Slingerland, Laurens V. Beerepoot, Tom Rozema, Mirjam A.G. Sprangers, Rob H.A. Verhoeven, Martijn G.H. van Oijen, Koos H. Zwinderman and Hanneke W.M. van Laarhoven

best supportive care. 5 , 6 However, even in the curative setting, outcome of these treatments is poor in esophageal and gastric cancer, with 5-year survival rates <50%, whereas treatment-related morbidity is high. 7 , 8 Therefore, patient